Lindus Health Introduces Its "All-in-One Women's Health CRO" for Clinical Trials in the Women's Health Space

News provided by

Oct 29, 2024, 08:00 ET

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched its "All-in-One Women's Health CRO" offering of contract research organization (CRO) and technology solutions bespoke to running clinical trials for women's health products.

Women have an increased risk of developing certain diseases like breast cancer, osteoporosis, autoimmune disorders, and more. They may also experience very different treatment responses to medications than men do. This is all due to hormone fluctuations, reproductive health, and other biological factors that must be accounted for in clinical trials for women's health interventions. Lindus Health is highly familiar with these nuances, allowing them to design and execute women's health research effectively.

Lindus Health's "All-in-One Women's Health CRO" solution harnesses its comprehensive CRO and site services and is built on their extensive experience in operating women's health clinical trials. Their multi-pronged recruitment tactics include screening from a repository of over 30 million electronic health records (EHRs), digital marketing, and collaborations with primary care, women's health clinics, and community groups. These capabilities enable sponsors to recruit diverse cohorts of participants twice as fast as traditional CROs in all study environments, including site-based, hybrid, and fully virtual settings.

To date, Lindus Health has enrolled over 2,500 patients in women's health clinical trials across the US, UK, and Europe. Their comprehensive offering provides companies developing treatments and diagnostics for women's health conditions with everything needed to manage their trials end-to-end, covering a wide range of indications such as pregnancy, postpartum depression, ovarian cancer, sexually transmitted infections (STIs), and more.

"Women have historically been underrepresented in clinical research, resulting in significant treatment disparities," said Emma Ogburn, Vice President of Clinical Operations of Lindus Health. "Here at Lindus, it's paramount that we help sponsors develop safe and reliable therapies for women by enrolling diverse, representative study populations while taking into account the unique aspects of their biology."

The "All-in-One Women's Health CRO" package equips women's health sponsors with a broad range of features to enhance their research:

End-to-end CRO services: From study initiation to completion, Lindus' clinical operations team manages all project-related and administrative activities for women's health trials.
Advanced recruitment strategies: Leveraging partnerships with primary care and women's health practices, EHR screening, digital marketing, and more, Lindus employs cutting-edge recruitment methods to quickly enroll diverse trial populations for women's health studies.
Flexible eClinical platform: Citrus^™, Lindus' proprietary clinical research management technology designed for each individual study, integrates essential tools such as clinical trial management software (CTMS), electronic data capture (EDC), telehealth, eConsent, and much more, providing everything needed for efficient trial management.
Expansive industry and regulatory knowledge: Lindus offers expert guidance in regulatory requirements and industry trends relevant to the women's health market segment.
Robust site services: Lindus' site operations team collaborates closely with principal investigators (PIs) and research teams to successfully manage women's health trials across various formats, including single-site, multi-site, virtual/hybrid, and traditional setups.

"Lindus has been a great partner in helping us conduct our clinical research," said Dr. Navid Khodaparast, Chief Scientific Officer at Spark Biomedical. "Their clear communication and proactive approach of handling all the 'what ifs' sets them apart from other CROs we've worked with. We really enjoy collaborating with them."

Lindus Health is dedicated to helping women's health sponsors bring groundbreaking therapies to the hands of patients by optimizing all facets of the research process, from study startup and planning through trial close-out and data delivery.

To learn more about Lindus Health's "All-in-One Women's Health CRO," click here.

About Lindus Health

Lindus Health is an anti-CRO running radically faster and more reliable trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 30 million Electronic Health Records.

Clinical trials are the biggest bottleneck to advances in healthcare. Lindus Health removes this constraint by handling the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management.

To date, Lindus Health has delivered clinical trials across the US, UK and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company has raised over $24M from investors including Peter Thiel, CREANDUM, Firstminute Capital, Seedcamp, Hambro Perks, Amino Collective and Calm/Storm.

Media Contact:
Jodi Perkins
Amendola for Lindus Health
[email protected]

SOURCE Lindus Health